SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-003191
Filing Date
2018-10-31
Accepted
2018-10-31 16:15:47
Documents
41
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q proteo_10q-093018.htm 10-Q 185487
2 CERTIFICATION proteo_ex3101.htm EX-31.1 9008
3 CERTIFICATION proteo_ex3102.htm EX-31.2 8989
4 CERTIFICATION proteo_ex32.htm EX-32 5211
  Complete submission text file 0001683168-18-003191.txt   1118158

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE pteo-20180930.xml EX-101.INS 110978
6 XBRL SCHEMA FILE pteo-20180930.xsd EX-101.SCH 15515
7 XBRL CALCULATION FILE pteo-20180930_cal.xml EX-101.CAL 31609
8 XBRL DEFINITION FILE pteo-20180930_def.xml EX-101.DEF 36735
9 XBRL LABEL FILE pteo-20180930_lab.xml EX-101.LAB 106810
10 XBRL PRESENTATION FILE pteo-20180930_pre.xml EX-101.PRE 88913
Mailing Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612
Business Address 2102 BUSINESS CENTER DRIVE IRVINE CA 92612 949-253-4616
PROTEO INC (Filer) CIK: 0001063104 (see all company filings)

IRS No.: 880292249 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30728 | Film No.: 181150509
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences